Administration of lipid-emulsion versus conventional amphotericin B in patients with neutropenia.

Pascual, B; Ayestaran, A; Montoro, J B; Oliveras, J; Estibalez, A; Julia, A; Lopez, A

Pascual, B; Ayestaran, A; Montoro, J B; Oliveras, J; Estibalez, A; Julia, A; Lopez, A.

Affiliation

Pascual B; Department of Pharmacy, Hospital Valle de Hebron, Barcelona, Spain.

Ann Pharmacother ; 29(12): 1197-201, 1995 Dec.

Article in En | MEDLINE | ID: mdl-8672820

Subject(s)

Amphotericin B/administration & dosage; Antifungal Agents/administration & dosage; Fat Emulsions, Intravenous/administration & dosage; Glucose/administration & dosage; Hematologic Diseases/complications; Neutropenia/drug therapy; Adolescent; Adult; Amphotericin B/therapeutic use; Antifungal Agents/adverse effects; Antifungal Agents/therapeutic use; Fat Emulsions, Intravenous/therapeutic use; Female; Glucose/adverse effects; Humans; Infusions, Intravenous; Male; Middle Aged; Mycoses/complications; Mycoses/drug therapy; Neutropenia/etiology; Prospective Studies; Solutions

Search on Google

XML

PubMed Links

Database: MEDLINE Main subject: Amphotericin B / Fat Emulsions, Intravenous / Glucose / Hematologic Diseases / Antifungal Agents / Neutropenia Type of study: Clinical_trials / Etiology_studies / Observational_studies / Risk_factors_studies Limits: Adolescent / Adult / Female / Humans / Male / Middle aged Language: En Year: 1995 Type: Article

Search on Google

XML

PubMed Links